Anbio Biotechnology (NNNN) Shares Outstanding (Weighted Average) (2023 - 2025)

Anbio Biotechnology's Shares Outstanding (Weighted Average) history runs 3 years deep, the most recent figure standing at $43.7 million for Q4 2025.

• In Q4 2025, Shares Outstanding (Weighted Average) rose 3.27% year-over-year to $43.7 million; the TTM figure through Dec 2025 stood at $43.7 million (up 3.27% YoY), while the FY2025 annual figure was $43.7 million, up 3.27% from the prior year.
• Shares Outstanding (Weighted Average) was $43.7 million for Q4 2025 at Anbio Biotechnology, up from $42.3 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $43.7 million in Q4 2025 to a low of $21.4 million in Q4 2023.
• Historically, Shares Outstanding (Weighted Average) has averaged $35.8 million across 3 years, with a median of $42.3 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Weighted Average) jumped 97.3% in 2024, then climbed 3.27% in 2025.
• A 3-year view of Shares Outstanding (Weighted Average) shows it stood at $21.4 million in 2023, then jumped by 97.3% to $42.3 million in 2024, then grew by 3.27% to $43.7 million in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $43.7 million (Q4 2025), $42.3 million (Q4 2024), and $21.4 million (Q4 2023), per Business Quant data.